Company Overview
- Headquarters
- 160 2nd St, Cambridge MA
- Website
- molecularinsight.com
- Employees
- 1
- Founded in
- 1997
- Industry
- Materials/Manufacturing
- SIC Code
-
2834 - Pharmaceutical Preparations
Financials & Stats
Revenue
$50B
Who is Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals, Inc. is a privately held company located in Cambridge, Massachusetts. The company employs 1 person and generates an estimated $50 million in annual revenue. Molecular Insight Pharmaceuticals specializes in the development of therapeutic radiopharmaceuticals and molecular imaging agents. These products are designed for use in oncology and cardiology, focusing on improving the detection of primary and metastatic prostate cancer, as well as providing systemic radiotherapy for relapsed and metastatic cases. Their portfolio includes technetium Tc 99m trofolastat, a molecular imaging agent in clinical trials for patients with metastatic prostate cancer. Additionally, they are developing 131I-MIP-1095, a prostate cancer therapy utilizing systemic radiotherapy. For more information, please visit molecularinsight.com.
Molecular Insight Pharmaceuticals Industry Tags
Companies Similar to Molecular Insight Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Molecular Insight Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | 8 | Boulder, CO | 1979 | |
| 50M | 70 | Wayne, PA | 2012 | |
| 50M | 66 | Woonsocket, RI | 1985 | |
| 50M | 14 | Irving, TX | ||
| 50M | 11 |